FDA Inspection
Apertus PharmaceuticalsApertus Pharmaceuticals – FDA Inspection, Oct 31, 2025
Record Details
This FDA Inspection record concerns Apertus Pharmaceuticals, with an inspection on October 31, 2025, issued by the Kansas City District Office, covering human drugs.
View Company Profile
ID · d2159b71-ad5c-474a-a568-a403b00cb157
Inspection Facts
- Inspection number
- 1293102
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Apertus Pharmaceuticals
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Apertus Pharmaceuticals
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.